Summarizes information on novel synthetic opioids that can appear in counterfeit pharmaceuticals and illicit street drugs. This bulletin defines novel synthetic opioids, such as fentanyl, and notes that the presence of these substances can…
Provides an overview of edible cannabis products, cannabis extracts and topical cannabis products. Outlines the differences among these products, including their use and effects.
Summarizes Canadian rates of calling 9-1-1 in drug poisoning situations, which greatly impacts the probability of surviving a drug-related overdose.
Provides information on the misuse of opioids in Canadian communities. This bulletin defines opioids and provides summaries of opioid misuse patterns and trends, most common route of administration and local responses in Vancouver, Saskatoon,…
This bulletin summarizes the risks and harms associated with nonmedical benzodiazepines and benzodiazepine-like substances that are increasingly being identified in drugs on the unregulated market, particularly drugs sold as opioids.…
Provides the action plan for the Canadian Centre on Substance Use and Addiction (CCSA) for the years 2021 through 2026. The strategic plan presents the Centre’s three strategic priorities and two North Star outcomes. It also outlines the methods…
Summarizes the increased risk of accidental overdose due to xylazine in Canada’s unregulated drug supply. Xylazine is a non-opioid pain reliever developed as a sedative and muscle relaxant for animals. It is being found as an adulterant in other…
